see all
  • Les Fermes Lufa A living economy 1:00
  • AJW Technique A living economy 1:00
  • Scandinave Spa A living economy 1:00

Press releases

November 13, 2019

ProteKt Therapeutics Raises $ US 3.6 Million in Post-incubation Financing

ProteKt Therapeutics, a biotech company developing new PKR kinase inhibitor based therapies for neurodegenerative diseases including Alzheimer’s Disease, today announced the signing of a binding agreement for a $ US 3.6 million equity financing round. The financing was co-led by Fonds de solidarité FTQ and Bukwang Pharmaceutical, together with existing investors FutuRx, OrbiMed, Johnson & Johnson Innovation – JJDC, Inc., Takeda Ventures, Inc. and RM Global Partners (RMGP) BioPharma Investment Fund. Proceeds from the financing will be used primarily to select a lead drug candidate molecule and validate its neurotherapeutic effects in vivo. In addition, the company plans to initiate the clinical development of a related diagnostic assay for patient selection and treatment personalization.

January 5, 2019

Fonds de solidarité FTQ Posts 12-Month Return of 5.8%

In the first six months of its 2017-2018 financial year, the Fonds de solidarité FTQ posted comprehensive income (profit) of $314 million for the benefit of its 667,000 savers. Share value is now $41.61, for a shareholder return of 2.2% for the six-month period ended November 30, 2018, and a 12-month return of 5.8%. Net assets grew to $14.8 billion.

Created in 1983, the Fonds de solidarité FTQ is a development capital fund that calls upon the solidarity and savings of Quebecers to help fulfill its mission to contribute to Québec's economic growth by creating and protecting jobs through investments primarily in small and medium-sized businesses in all spheres of activity.

The Fonds also seeks to encourage Quebecers to save for retirement and to offer its over half a million shareholders-savers a reasonable return over and above the outstanding tax benefits they receive for purchasing Fonds shares. A leading purveyor of unsecured risk capital (growth and venture capital), the Fonds continues to drive our economy.

Please read the prospectus before buying Fonds de solidarité FTQ shares. Copies of the prospectus, from a local representative or at the offices of the Fonds de solidarité FTQ. The shares of the Fonds de solidarité FTQ are not guaranteed, their value changes and past performance may not be repeated.